Human Microbiome Market Players:
- Seres Therapeutics, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Evelo Biosciences, Inc.
- Synlogic, Inc.
- Second Genome Inc.
- Synthetic Biologics, Inc.
- YSOPIA Bioscience
- 4D Pharma plc
- DuPont de Nemours, Inc.
- BiomX Inc.
- Sun Genomics, Inc.
- Viome Life Sciences, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of human microbiome is assessed at USD 1.66 billion.
The global human microbiome market size was valued at around USD 1.37 billion in 2025 and is projected to grow at a CAGR of more than 23.5%, reaching USD 11.31 billion revenue by 2035.
North America human microbiome market will hold around 35% share by 2035, driven by rising pet adoption and increasing prevalence of lifestyle diseases.
Key players in the market include Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, Inc., Second Genome Inc., Synthetic Biologics, Inc., YSOPIA Bioscience, 4D Pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc.
